# A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia

> **NCT02553187** · PHASE4 · UNKNOWN · sponsor: **Zhejiang Kanglaite Pharmaceutical Co.Ltd** · enrollment: 160 (estimated)

## Conditions studied

- Cancer Cachexia

## Interventions

- **DRUG:** Kanglaite Injection

## Key facts

- **NCT ID:** NCT02553187
- **Lead sponsor:** Zhejiang Kanglaite Pharmaceutical Co.Ltd
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2017-07
- **Final completion:** 2018-07
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2017-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02553187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02553187, "A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02553187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*